Related Experiment Video
Updated: Feb 20, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
Magnesium as a new player in CKD: too little is as bad as too much?
Naoto Hamano1, Hirotaka Komaba2, Masafumi Fukagawa1
1Division of Nephrology, Endocrinology and Metabolism, Tokai University School of Medicine, Isehara, Japan.
Insights
Magnesium supplementation effectively prevents vascular calcification in chronic kidney disease models. This finding offers a promising therapeutic strategy, though potential bone metabolism effects require consideration.
Area of Science:
- Nephrology
- Cardiovascular Medicine
- Biochemistry
Background:
- Vascular calcification is a significant complication in chronic kidney disease (CKD).
- Current treatments for vascular calcification in CKD are inadequate.
- Magnesium is recognized for its potential to inhibit calcification processes.
Purpose of the Study:
- To investigate the efficacy of magnesium supplementation in preventing vascular calcification progression.
- To determine if magnesium's effects are independent of phosphate binding.
Main Methods:
- Utilized a uremic rat model to study vascular calcification.
- Administered magnesium supplementation to the model.
- Assessed the impact of magnesium on vascular calcification progression.
Main Results:
- Magnesium supplementation demonstrated a preventative effect on vascular calcification progression.
- This inhibitory effect was observed independently of the rats' phosphate-binding capacity.
- Potential adverse effects of excessive magnesium on bone metabolism were noted.
Conclusions:
- Magnesium supplementation is a promising therapeutic approach for inhibiting vascular calcification in CKD.
- The mechanism of action appears independent of phosphate binding.
- Further research is needed to balance efficacy with potential bone health risks.
Abstract:
Vascular calcification is a serious complication of chronic kidney disease, but the current therapeutic strategy is insufficient for preventing its progression. Magnesium is a potent inhibitor of calcification and represents a promising therapeutic candidate. Diaz-Tocados and colleagues now demonstrate that magnesium supplementation prevents the progression of vascular calcification in a uremic rat model, independently of the phosphate-binding capacity. We should keep in mind, however, that too much magnesium could have adverse effects on bone metabolism.
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease IV: Nursing Management
Chronic Kidney Disease II: Clinical Manifestations
Introduction to Electrolytes
Role of Sodium
One...
Acute Kidney Injury V: Interprofessional Care

